We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




European Laboratory Information Systems Market

By Labmedica staff writers
Posted on 23 Nov 2006
The classic laboratory information system (LIS), designed as a multi-functional system to support hospital laboratory activities with emphasis on work and specimen flow for hospital inpatients and outpatients, has been dominant in clinical laboratories for more than three decades. More...
This has led to 90-95% market penetration levels for LIS software.

According to Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm, the European laboratory information systems market earned revenues of U.S.$153.7 million in 2005 and is estimated to reach U.S.$218.1 million in 2012.

Hospital laboratories are changing rapidly with greater emphasis on point-of-care and outreach testing, working in tandem with other automated systems in the hospital. Across Europe, almost half of the hospitals have a dedicated laboratory system. Vendors have therefore seen this as an opportunity to persuade hospitals of the benefits of an integrated hospital-wide system using the LIS as a selling tool.

"For many hospitals, the changes in LIS are related to a drive to connect together various hospital departments and departmental software,” explained Frost & Sullivan industry analyst Konstantinos Nikolopoulos. "Clinicians want to be able to enter data into electronic records and they want to both import and export data from electronic medical records [EMR] and hospital information systems [HIS] to LIS and vice-versa.”

Past trends have indicated that customers do not switch over to new vendors very easily, either due to financial considerations or simply to avoid the process of implementing new systems. "Market participants will need to show increased visibility in such a competitive environment,” advises Mr. Nikolopoulos. "Attendance and participation in trade shows and other industry-wide events can build company awareness, while the ability to highlight product capabilities and features in test/pilot sites can be an additional step in the same direction.”




Related Links:
Frost & Sullivan

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gastrointestinal Panel
Xpert® GI Panel
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.